Biocompatibility: is it a relevant consideration for today's haemodialysis?
Shaldon
S
S
Vienken
J
J
D000686:Amyloidosis / Q000209:etiology; D000706:Anaphylatoxins / Q000378:metabolism; D001672:Biocompatible Materials / Q000009:adverse effects / Q000592:standards*; D003167:Complement Activation; D004731:Endotoxins / Q000097:blood; D017743:Equipment Reuse; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000628:therapy; D007970:Leukopenia / Q000209:etiology; D008567:Membranes, Artificial; D011506:Proteins / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects / Q000401:mortality / Q000592:standards
D000706:Anaphylatoxins; D001672:Biocompatible Materials; D004731:Endotoxins; D008567:Membranes, Artificial; D011506:Proteins